Evidence map›Paper›PMID 31942933›Full record

ArticleThe Biochemical journal2020

A malaria parasite subtilisin propeptide-like protein is a potent inhibitor of the egress protease SUB1.

Sarah J Tarr, Chrislaine Withers-Martinez, Helen R Flynn, Ambrosius P Snijders, Laura Masino, Konstantinos Koussis, David J Conway, Michael J Blackman

Abstract read
In one paragraph

Article in The Biochemical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Subtilisin ofCurrent issues in molecular biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah J TarrFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.
Chrislaine Withers-MartinezMalaria Biochemistry Laboratory, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, U.K.
Helen R FlynnProtein Analysis and Proteomics Platform, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, U.K.
Ambrosius P SnijdersProtein Analysis and Proteomics Platform, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, U.K.
Laura MasinoStructural Biology Science Technology Platform, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, U.K.
Konstantinos KoussisMalaria Biochemistry Laboratory, The Francis Crick Institute, 1 Midland Rd, London NW1 1AT, U.K.
David J ConwayFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.
Michael J BlackmanFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.

Funding

Cancer Research UK FC001043Medical Research Council FC001043Wellcome Trust FC001043
6 · The paper itself

Abstract

Subtilisin-like serine peptidases (subtilases) play important roles in the life cycle of many organisms, including the protozoan parasites that are the causative agent of malaria, Plasmodium spp. As with other peptidases, subtilase proteolytic activity has to be tightly regulated in order to prevent potentially deleterious uncontrolled protein degradation. Maturation of most subtilases requires the presence of an N-terminal propeptide that facilitates folding of the catalytic domain. Following its proteolytic cleavage, the propeptide acts as a transient, tightly bound inhibitor until its eventual complete removal to generate active protease. Here we report the identification of a stand-alone malaria parasite propeptide-like protein, called SUB1-ProM, encoded by a conserved gene that lies in a highly syntenic locus adjacent to three of the four subtilisin-like genes in the Plasmodium genome. Template-based modelling and ab initio structure prediction showed that the SUB1-ProM core structure is most similar to the X-ray crystal structure of the propeptide of SUB1, an essential parasite subtilase that is discharged into the parasitophorous vacuole (PV) to trigger parasite release (egress) from infected host cells. Recombinant Plasmodium falciparum SUB1-ProM was found to be a fast-binding, potent inhibitor of P. falciparum SUB1, but not of the only other essential blood-stage parasite subtilase, SUB2, or of other proteases examined. Mass-spectrometry and immunofluorescence showed that SUB1-ProM is expressed in the PV of blood stage P. falciparum, where it may act as an endogenous inhibitor to regulate SUB1 activity in the parasite.

Indexed as

Amino Acid SequenceAnimalsErythrocytesGenomeHumansLife Cycle StagesMalaria, FalciparumPeptide HydrolasesPlasmodium falciparumProteolysisProtozoan ProteinsSerine ProteasesSubtilisinVacuolesPeptide HydrolasesProtozoan ProteinsSerine ProteasesSubtilisinparasitophorous vacuolePlasmodium falciparumpropeptidesubtilase

Identifiers

PMID31942933
PMCPMC6993865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.